These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16475730)

  • 1. Evaluation of a series of new 99mTc-labeled bombesin-like peptides for early cancer detection.
    Gourni E; Paravatou M; Bouziotis P; Zikos C; Fani M; Xanthopoulos S; Archimandritis SC; Livaniou E; Varvarigou AD
    Anticancer Res; 2006; 26(1A):435-8. PubMed ID: 16475730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, radiolabelling and biological characteristics of a bombesin peptide analog as a tumor imaging agent.
    Okarvi SM; al-Jammaz I
    Anticancer Res; 2003; 23(3B):2745-50. PubMed ID: 12894569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies.
    Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Volkert WA; Hoffman TJ
    Anticancer Res; 2003; 23(1A):63-70. PubMed ID: 12680195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.
    Kunstler JU; Veerendra B; Figueroa SD; Sieckman GL; Rold TL; Hoffman TJ; Smith CJ; Pietzsch HJ
    Bioconjug Chem; 2007; 18(5):1651-61. PubMed ID: 17663527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys 3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours.
    Ferro-Flores G; Arteaga de Murphy C; Rodriguez-Cortés J; Pedraza-López M; Ramírez-Iglesias MT
    Nucl Med Commun; 2006 Apr; 27(4):371-6. PubMed ID: 16531924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabeling of bombesin-like peptide with 99mTc: 99mTc-litorin and biodistribution in rats.
    Durkan K; Lambrecht FY; Unak P
    Bioconjug Chem; 2007; 18(5):1516-20. PubMed ID: 17760415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of a 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors.
    La Bella R; Garcia-Garayoa E; Langer M; Bläuenstein P; Beck-Sickinger AG; Schubiger PA
    Nucl Med Biol; 2002 Jul; 29(5):553-60. PubMed ID: 12088725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical and biological characterization of new Re(CO)3/[99mTc](CO)3 bombesin analogues.
    García Garayoa E; Rüegg D; Bläuenstein P; Zwimpfer M; Khan IU; Maes V; Blanc A; Beck-Sickinger AG; Tourwé DA; Schubiger PA
    Nucl Med Biol; 2007 Jan; 34(1):17-28. PubMed ID: 17210458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging.
    Nock B; Nikolopoulou A; Chiotellis E; Loudos G; Maintas D; Reubi JC; Maina T
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):247-58. PubMed ID: 12552343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors.
    García Garayoa E; Schweinsberg C; Maes V; Rüegg D; Blanc A; Bläuenstein P; Tourwé DA; Beck-Sickinger AG; Schubiger PA
    Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):42-50. PubMed ID: 17372572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new high affinity technetium-99m-bombesin analogue with low abdominal accumulation.
    Lin KS; Luu A; Baidoo KE; Hashemzadeh-Gargari H; Chen MK; Brenneman K; Pili R; Pomper M; Carducci MA; Wagner HN
    Bioconjug Chem; 2005; 16(1):43-50. PubMed ID: 15656574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of functionalized coligands on the pharmacokinetics of 99mTcIII '4+1' mixed-ligand complexes conjugated to bombesin.
    Kunstler JU; Bergmann R; Gniazdowska E; Koźmiński P; Walther M; Pietzsch HJ
    J Inorg Biochem; 2011 Nov; 105(11):1383-90. PubMed ID: 21946438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
    Chen X; Park R; Hou Y; Tohme M; Shahinian AH; Bading JR; Conti PS
    J Nucl Med; 2004 Aug; 45(8):1390-7. PubMed ID: 15299066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors.
    Zhang H; Chen J; Waldherr C; Hinni K; Waser B; Reubi JC; Maecke HR
    Cancer Res; 2004 Sep; 64(18):6707-15. PubMed ID: 15374988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14).
    Biddlecombe GB; Rogers BE; de Visser M; Parry JJ; de Jong M; Erion JL; Lewis JS
    Bioconjug Chem; 2007; 18(3):724-30. PubMed ID: 17378600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
    Faintuch BL; Teodoro R; Duatti A; Muramoto E; Faintuch S; Smith CJ
    Nucl Med Biol; 2008 May; 35(4):401-11. PubMed ID: 18482677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 99mTc(CO)3-DTMA bombesin conjugates having high affinity for the GRP receptor.
    Lane SR; Veerendra B; Rold TL; Sieckman GL; Hoffman TJ; Jurisson SS; Smith CJ
    Nucl Med Biol; 2008 Apr; 35(3):263-72. PubMed ID: 18355681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted imaging of gastrin-releasing peptide receptors with 99mTc-EDDA/HYNIC-[Lys3]-bombesin: biokinetics and dosimetry in women.
    Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Pichardo-Romero PA
    Nucl Med Commun; 2008 Aug; 29(8):741-7. PubMed ID: 18753829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiochemical investigations of gastrin-releasing peptide receptor-specific [(99m)Tc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, tumor-bearing, rodent models: syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2,3-diaminopropionic acid and X = H2O or P(CH2OH)3.
    Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Kannan R; Volkert WA; Hoffman TJ
    Cancer Res; 2003 Jul; 63(14):4082-8. PubMed ID: 12874010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent.
    La Bella R; Garcia-Garayoa E; Bahler M; Bläuenstein P; Schibli R; Conrath P; Tourwé D; Schubiger PA
    Bioconjug Chem; 2002; 13(3):599-604. PubMed ID: 12009951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.